Ilico Genetics
Ilico Genetics, a Spin Off of Pontificia Universidad Católica de Chile, is developing the first methylated DNA based molecular test specifically designed for the early detection of gastric cancer, even years before Esophagogastroduodenoscopy (EGD, gold standard). With only a blood sample, and even without symptoms, it detects a tumor in the stomach or lesions that could evolve to gastric cancer. The results are dynamic and show the cumulative presence of tumors over time.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Ilico Genetics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- MW
Matthew West
Lead Developer · Engineering
EmailPhone - FA
Fernando Alarcon Hardy
Co-founder & CEO · General Business & Management
EmailPhone
Showing 2 of 5 verified contacts
Top roles at Ilico Genetics
5 distinct titles indexed · top 5 shown.
- 1co-founder & ceo
- 1co-founder & coo
- 1intern
- 1lead developer
- 1social media and graphic design intern
Sign up to unlock all 5 contacts at Ilico Genetics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Ilico Genetics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.